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Abstract
Background: In order to study the sites of uptake and mechanisms of dissemination of scrapie
prions in the natural host under controlled conditions, lambs aged 14 days and homozygous for the
VRQ allele of the PrP gene were infected by the oral route. Infection occurred in all lambs with a
remarkably short and highly consistent incubation period of approximately 6 months. Challenge of
lambs at approximately eight months of age resulted in disease in all animals, but with more variable
incubation periods averaging significantly longer than those challenged at 14 days.
This model provides an excellent system in which to study the disease in the natural host by virtue
of the relatively short incubation period and close resemblance to natural infection.
Results: Multiple sites of prion uptake were identified, of which the most important was the
Peyer's patch of the distal ileum.
Neuroinvasion was detected initially in the enteric nervous system prior to infection of the central
nervous system. At end stage disease prion accumulation was widespread throughout the entire
neuraxis, but vacuolar pathology was absent in most animals that developed disease at 6–7 months
of age.
Conclusion: Initial spread of detectable PrP was consistent with drainage in afferent lymph to
dependent lymph nodes. Subsequent accumulation of prions in lymphoid tissue not associated with
the gut is consistent with haematogenous spread. In addition to macrophages and follicular
dendritic cells, prion containing cells consistent with afferent lymph dendritic cells were identified
and are suggested as a likely vehicle for carriage of prions from initial site of uptake to the
lymphoreticular system, and as potential carriers of prion protein in blood. It is apparent that
spongiform change, the characteristic lesion of scrapie and other prion diseases, is not responsible
for the clinical signs in sheep, but may develop in an age dependent manner.
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Background
Scrapie is a transmissible spongiform encephalopathy
(TSE), an infectious neurodegenerative disease of sheep,
goats and moufflon, endemic in many countries of the
Northern hemisphere and characterised by extremely long
incubation periods, frequently of many years. As a disease
of sheep, scrapie has been known for centuries in Europe.
The emergence of bovine spongiform encephalopathy
(BSE) in the UK [1], a disease of cattle possibly derived
from scrapie that has given rise to a new form of Creut-
zfeldt-Jakob disease in humans, vCJD [2], has raised the
profile of scrapie in sheep.
Etiologically scrapie has been variously thought of as
hereditary or due to a slow virus infection. The cause is
now thought to be a prion, an abnormal isoform of the
host's own cellular prion protein PrPC, misfolded to give
PrPSc, probably the sole constituent of the infectious prion
[3]. Infection with scrapie prions follows a familial pat-
tern and is known to be associated with susceptible alleles
of the prion protein gene [4].
Infection with the agent is widespread throughout lym-
phoid and central nervous system tissues of the body of
infected sheep, but the clinical signs are of a nervous dis-
ease and typically feature changes in behaviour, pruritus,
ataxia, trembling and weigh loss leading ultimately and
invariably to death.
Studies on the pathogenesis of scrapie as a natural infec-
tion in sheep have shown that the infectious agent accu-
mulates in tissues of the gut and lymphoreticular system
early in the incubation period, preceding invasion of the
nervous system [5]. More recently, and following the
development of the prion hypothesis to account for the
infectious agent, more detailed studies which use detec-
tion of the prion protein have been possible, in preference
to bioassays. Such studies, using immunohistochemistry
applied to sheep naturally infected with scrapie, have ena-
bled the distribution of prion protein throughout the
incubation period to be mapped at the cellular level [6,7],
and have considerably enhanced current understanding
of the natural disease. In all such studies however, the tim-
ing of infection is unknown as routes and mechanisms of
transmission of natural scrapie are obscure.
It is generally thought that sheep become infected early in
life, but in natural disease the exact timing of infection is
never known and infection may occur repeatedly through-
out the course of the disease; adult sheep are certainly sus-
ceptible to scrapie infection [8]. The route of infection is
likely to be oral in the majority of cases of natural scrapie,
based on either neural targeting of the agent [9] or initial
detection of infection in lymphoid tissues of the gastroin-
testinal tract, in particular the Peyer's patches (PP) of the
distal ileum [6,7]. Initial uptake from the gut lumen prob-
ably occurs by transcytosis of prions by specialised epithe-
lial cells, M cells. Replication and accumulation of the
agent is associated with macrophages and follicular den-
dritic cells in advance of detectable PrP in the enteric nerv-
ous system, which in turn precedes invasion of the central
nervous system, the onset of clinical disease and the vacu-
olar pathology typical of scrapie and related disorders.
Exact mechanisms of spread to lymphoid tissues are
uncertain. Infection of blood has long been suspected and
has recently been demonstrated unequivocally in experi-
mental BSE infection of sheep[10].
Due to the difficulties of working with the natural disease,
in particular the extremely long incubation periods,
rodent models of scrapie infection have been widely used
to study pathogenesis, and show many similarities to the
natural disease. Whilst the use of rodents has many advan-
tages and has been highly productive, it is apparent that
most natural prion infections occur in ruminants. There
are clear limitations to studying the pathogenesis in
monogastric rodents that do not appear to be able to
transmit the disease naturally, although precise knowl-
edge of the timing of infection in experimental models
has advantages.
Experimental infections of sheep with scrapie have used
predominantly parenteral challenges; the current under-
standing of genetic susceptibility of sheep to scrapie was
established using susceptibility to subcutaneous inocula-
tion [11,12]. Challenges using the presumed natural
(oral) route of challenge have been reported in the litera-
ture. One study used 5 month old sheep homozygous for
the ARQ allele of the PrP gene, not all of which suc-
cumbed to disease following challenge with an inoculum
made from spleen and brain of affected sheep [12,13].
Oral challenge of lambs homozygous or heterozygous for
the VRQ allele of the PrP gene showed accumulation of
prion protein in the PP when maintained for up to 11
months post challenge, but in that study none were
allowed to progress to clinical disease [14]. Oral challenge
of ARQ homozygous sheep with the BSE agent has been
used to study pathogenesis of BSE infection of sheep
[15,16]. In this study a sequential accumulation of disease
specific PrP was detected in lymphoid tissues prior to neu-
roinvasion, very similar to that occurring in scrapie. No
such detailed study of scrapie pathogenesis in the natural
host under carefully controlled conditions has been
described.
We report an experimental model of scrapie infection in
which scrapie-free sheep of known genetic susceptibility
were challenged orally at a young age, before weaning. In
this model there was a rapid onset of disease, leading to
clinical scrapie after a precisely known and remarkablyBMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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short incubation period, averaging 188 days (time to
euthanasia). The model provides the known time of infec-
tion and high consistency found in rodent models, but in
the natural host and with comparable or shorter incuba-
tion periods. The experimental disease closely resembled
the natural disease, confirming this as an ideal model for
studying scrapie under controlled conditions. Immuno-
histochemistry for disease specific PrP (PrPd) enabled the
distribution and spread of the infection to be described in
detail throughout the incubation period.
Results
Clinical disease
Initial onset of clinical signs, in particular changes in
behaviour and a subtle increase in nervousness, was noted
from approximately 4 months post infection (mpi).
Increased nervousness, pruritus and ataxia were com-
monly observed, and occurred in all scrapie-challenged
sheep except those killed at pre-determined time points
early in the incubation period. Table 1 shows incubation
periods for each group. Euthanasia as a result of onset of
definite clinical signs was carried out after a mean interval
of 185 days in the 5 g dose group and 192 days in the 1 g
dose group. Disease was confirmed by identification of
widespread PrPd accumulation in the CNS by immunohis-
tochemistry (Fig 1a) and detection of proteinase K resist-
ant PrPSc by Western blotting.
Cellular distribution of PrPd in lymphoid tissues
Three types of cell labelled for PrPd could be distinguished
in lymphoid tissues, based on morphology, PrP immu-
nolabeling and location:
The predominant cell type labelled was a large cell with
irregular shaped nucleus, containing one or several large
and intensely labelled deposits of PrP (Fig 2). Based on
these features these cells are tentatively identified as mac-
rophages, and were detected within germinal centres of all
lymphoid tissues, the inter-follicular areas of tonsil and
lymph nodes, germinal centres and marginal zones of the
spleen and subcapsular sinuses of lymph nodes.
The morphology and location of some immunolabelled
cells in the domes of Peyer's patches (Fig 2a), subcapsular
sinus of lymph nodes, and some interfollicular areas (Fig
2b) are suggestive of dendritic cells.
Branching patterns of immunolabeling of moderate
intensity and even distribution but difficult to associate
with individual nuclei were commonly detected in germi-
nal centres (Fig 2). This was tentatively identified as
immunolabeling of follicular dendritic cells (FDC).
Anatomical distribution of PrPd in gut associated lymphoid 
tissues
Table 2 shows the timing of detection of PrPd in tonsils,
PP and draining lymph nodes. Due to the similarity of the
incubation periods and disease progression in the 5 g and
1 g dose groups, data from both are considered together in
the results. No PrPd was detected in animals killed at 3, 8
and 14 days post infection (dpi). Initial detection of PrPd
was in the PP of the distal ileum, in a single animal 21 dpi
and in 5/6 animals at 28 dpi. In these animals this con-
sisted of immunolabeling of a very small number of lym-
phoid follicles only. Immunolabeled macrophages were
observed in the follicles of the PP, and less commonly in
Medulla oblongata at the level of the obex Figure 1
Medulla oblongata at the level of the obex. a) Widespread immunolabeling of moderate to marked intensity in the 
hypoglossal nucleus (bottom right) and dorsal motor nucleus of the vagus nerve (centre). Scale bar 500 μm. b) Equivocal vacu-
olation in the ventral border of the dorsal motor nucleus of the vagus nerve. Scale bar 500 μm.BMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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the domes. Immunolabeling was confined to a small
number of cells within each PP follicle and only a minor-
ity of follicles showed any positive cells.
In addition to the distal ileum, PrPd was also detected in
PP of jejunum in one animal at 28 dpi.
In the palatine tonsil of one lamb at 28 dpi just two lym-
phoid follicles and numerous cells scattered between the
positive follicles and the tonsil sinus were labelled.
In another lamb there was immunolabeling of the medial
retropharyngeal lymph nodes, involving only a few posi-
tive cells within a few follicles. In this lamb there was no
immunolabeling in either the palatine or pharyngeal ton-
sil.
In three control sheep killed at 27 dpi there was no PrP
immunolabeling in any tissues.
At 55 dpi PrPd was more widespread, involving a greater
number of PP follicles in the distal ileum and to a lesser
extent in the jejunum. The draining lymph nodes of the
small intestine, the mesenteric lymph nodes, were posi-
tive in only one of these sheep. The palatine, and to a
lesser extent pharyngeal, tonsils were positive at this time
point, as were the draining lymph nodes, the medial ret-
ropharyngeal nodes. In palatine tonsils most follicles were
Table 1: Incubation periods
Group Challenge Age at challenge (days) Attack rate Mean incubation period (days)
Range, (SD)
1 1 g RBP1 oral 14 25/25 192
185–204, (6.9)
2 5 g RBP1 oral 14 28/28 185
178–198, (7.4)
3 1 g RBP1 oral (after 3 g scrapie negative sheep brain) 245 8/8 345
198–639, (186)
4 Exposure to groups 1 and 2 42 days onwards 4/4 649*
592–716, (61)
5 3 g Scrapie negative sheep brain 14 days 8/8 1085**
880–1231 (156)
* Days since mixing with groups 1 and 2
** Age at death, as exact timing of infection unknown
Immunolabeling in lymphoreticular tissues Figure 2
Immunolabeling in lymphoreticular tissues. a) Distal ileum. Large, intensely labelled PrPSc deposits in macrophages in 
the germinal centres of Peyer's patch follicles (centre bottom) and the overlying dome (arrows). Diffuse, branching PrPd depos-
its are consistent with labeling of follicular dendritic cells. Scale bar 100 μm. b) Mesenteric lymph node. Macrophage and follic-
ular dendritic cell labeling, as well as putative veiled afferent dendritic cells in the subcapsular and interfollicular areas (arrows). 
Scale bar 100 μm.BMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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negative but the few positive follicles occurred in clusters,
not scattered, suggesting a focus of infection entering sev-
eral follicles, or spread locally to adjacent follicles. In all
cases PrPd labeling was detected mainly as large irregular
deposits in macrophages within germinal centres of the
lymphoid follicles. There was also labeling of some irreg-
ularly shaped cells in the extra-follicular areas of tonsils
and the cortices of lymph nodes. Occasional immunola-
beled macrophages were observed in the subcapsular
sinuses of lymph nodes. In all animals at this time point
the majority of lymphoid follicles showed no evidence of
PrPd accumulation.
At 81 dpi PrPd was detected in all 10 animals killed, and
more widely than at earlier time points. Intense labeling
for PrPd was present in PP of distal ileum of all sheep,
involving several or most lymphoid follicles but some fol-
licles were negative in all sheep. PrPd was also detected in
the jejunal PP and in mesenteric lymph nodes of most
animals. In PP at this time point PrPd positive macro-
phages were abundant, and in some follicles there was
also prominent labeling of FDC. In some there was also
intense immunolabeling of cells in the dome and in the
capsule of the follicle. Pharyngeal and palatine tonsils of
most sheep were positive and PrPd was detected in the
medial retropharyngeal lymph node of all 10, but was rare
in the lateral retropharyngeal lymph node, which receives
afferent lymph from the medial node. In all of these loca-
tions larger numbers of follicles were found to be positive
than at earlier time points and the immunolabeling was
more intense, involving immunolabeling of both macro-
phages and FDCs in many follicles. In addition positively
labelled cells were observed in the inter-follicular areas
and occasionally in the subcapsular sinuses of mesenteric
and medial retropharyngeal nodes.
At 110 and 147 dpi PrPd was detectable in most lymphoid
tissues associated with the GI tract, and in these tissues
most lymphoid follicles were positive. At this time point
a combination of macrophages and FDC within follicles
showed intense immunolabeling for PrPd. Many positive
macrophage-like cells were also observed in the inter-fol-
licular areas and subcapsular sinuses of the lymph node
cortices, particularly in the medial retropharyngeal and
mesenteric nodes.
During the clinical stages of disease intense immunolabe-
ling of both macrophages and FDCs was found in virtu-
ally all follicles of all the gut associated lymphoid tissues.
Abundant immunolabeled macrophages in the subcapsu-
lar sinuses were also observed in many lymph nodes at
this time point. These were particularly prominent in the
medial retropharyngeal lymph nodes and mesenteric
lymph nodes, both of which directly drain heavily
affected tissues: the tonsils and small intestine respec-
tively. The lateral retropharyngeal lymph nodes, which
receive afferent lymph from the medial retropharyngeal
nodes, showed consistently less immunolabeling for PrPd.
Immunohistochemistry of other lymphoid tissues
Timing of detection of PrPd in spleen and in lymph nodes
not draining the GI tract is shown in Table 3. No PrPd was
detected in animals killed prior to 81 dpi. Initial detection
in these tissues was in some sheep only, at 81 dpi. In all
cases this involved only occasional lymph nodes, very few
follicles in each lymph node and predominantly in mac-
rophages only. At this time point immunolabeling in the
spleen was confined to the germinal centres of peri-arteri-
olar lymphoid sheaths.
At 110 dpi, 147 dpi and in clinical disease PrPd was wide-
spread and was detected in most lymphoid tissues. The
intensity and extent of PrPd detection varied but at least
some follicles were labelled in all lymph nodes examined
from all animals.
Table 2: Disease specific PrP (PrPd) detection in gastrointestinal tract and associated lymphoid and nervous tissues in pre-clinical 
stages of disease
Tissue Time post infection (days)
Number positive/number examined
(21) (28) (55) (81) (110) (147)
Distal ileum Peyer's patch 1/3 5/6 8/8 10/10 10/10 3/3
Jejunum Peyer's patch 0/3 1/4 6/8 8/10 9/9 3/3
Mesenteric lymph node 0/3 0/6 1/8 7/10 10/10 3/3
Palatine tonsil 0/3 1/6 4/7 9/10 9/10 3/3
Pharyngeal tonsil 0/3 0/6 3/8 8/10 10/10 2/3
Medial retropharyngeal lymph node 0/3 1/6 5/8 10/10 10/10 3/3
Lateral retropharyngeal lymph node 0/3 Nd 0/5 3/10 7/9 3/3
Enteric nervous system 0/3 0/6 0/8 0/10 10/10 2/3
nd: not done
No disease specific PrPd detected in any animals killed at 3, 8 and 14 days post infection.BMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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In the spleen the extent and intensity of immunolabeling
of PrP was less than in other lymphoid tissues. Small
numbers of macrophages were labelled within germinal
centres and marginal zones of many, but not all, periarte-
riolar lymphoid sheaths.
At clinical disease much more intense labeling was
detected, in some germinal centres in the spleen including
FDCs and macrophages, similar to that seen in lymph
nodes. Many lymph nodes including popliteal and pre-
scapular lymph nodes, which receive afferent lymph from
the hind and forelimbs respectively, also showed labelled
macrophages in the subcapsular sinuses.
PrPd accumulation in inflammatory lymphoid tissue
In some sheep, in which transient episodes of incidental
pneumonia had occurred, there was hypertrophy of the
bronchial associated lymphoid tissue giving rise to germi-
nal centre formation. In all such cases in scrapie chal-
lenged sheep there was accumulation of PrPd  in this
organised lymphoid tissue (Fig 3), predominantly in mac-
rophages, similar to that in lymph nodes.
In one sheep there was unilateral enlargement of the sub-
mandibular lymph node, probably associated with an
(undetected) unilateral inflammatory process in the oral
cavity. The enlarged lymph node contained a large
number of secondary follicles, in contrast to very few in
the much smaller, non-reactive contra-lateral node. In this
sheep there was extensive accumulation of PrPd in the
reactive node, where all the secondary follicles contained
labelled macrophages and FDC, whereas there was virtu-
ally no PrPd detectable in the non-reactive lymph node.
Central nervous system
All animals were similar and showed a PrPd accumulation
consisting of a combination of particulate, intra-neuro-
nal, and intra-glial labeling in the grey matter of the spinal
cord and brain.
Examination of spinal cord sections at the following lev-
els: cervical segment 8, thoracic segments 1, 6 and 12 and
lumbar segment 4, showed no infection at 110 dpi, but
the brain stem was infected at this time point in 7/10
sheep. In all cases this was confined to weak immunola-
beling of neurons along the ventral border of the dorsal
motor (parasympathetic) nucleus of the vagus nerve, and
was bilaterally symmetrical. At 147 dpi there was a greater
involvement of the brain stem; all neurons of the dorsal
motor (parasympathetic) nucleus of the vagus nerve
showed fine particulate deposits and there was wide-
spread but weak immunolabeling of glia and some neu-
rons throughout the medulla (Fig 1a). Small amounts of
labeling were seen in the spinal cord, intra-glial labeling
at most levels in the intermedio-medial grey matter, and
neuronal labeling of the intermedio-lateral grey matter,
the source of sympathetic outflow, in all three animals
examined.
Table 3: Disease specific PrP (PrPd) detection in non-gastrointestinal associated lymphoid tissues
Tissue Time post infection (days)
Number positive/number examined
(28) (55) (81) (110) (147) (Clinical)
Spleen 0/6 0/8 3/10 10/10 3/3 15/15
Broncho-mediastinal lymph node nd 0/8 3/10 10/10 3/3 9/10
Tracheo-bronchial lymph node nd 0/8 2/10 8/9 3/3 8/8
Popliteal lymph node 0/6 0/8 0/10 9/10 3/3 10/10
Pre-scapular lymph node nd 0/8 2/10 7/8 3/3 10/10
Inguinal lymph node nd 0/8 4/10 10/10 3/3 9/10
Submandibular lymph node nd 0/8 2/10 10/10 3/3 10/10
nd: not done
Immunolabeling of macrophages in a lymphoid follicle in the  lung Figure 3
Immunolabeling of macrophages in a lymphoid folli-
cle in the lung. Scale bar 100 μm.BMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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At end stage disease the extent of PrPd distribution in the
brain had increased to involve all grey matter areas. Weak
particulate labeling of the perikaryon was observed in vir-
tually all neurons, together with intra-glial deposits. No
large accumulations of PrPd  amyloid plaques were
observed and neuropil labeling was mild (Fig 1a). The spi-
nal cord showed a similar pattern of perikaryonal and
intra-glial deposits throughout the grey matter at end
stage disease.
Histopathological examination of brains showed mini-
mal or no lesions in the medulla oblongata at the level of
the obex (Fig 1b), the site most typically affected by vacu-
olar pathology in scrapie affected sheep [18]. Elsewhere in
the brain vacuolar pathology was sparse or absent, but in
some sheep vacuolation of the hypothalamus was identi-
fied, even in the absence of vacuolation in the medulla
oblongata.
Peripheral nervous system
Table 4 shows the timing of detection of PrPd in periph-
eral nervous tissues. No labeling of PrP in the enteric nerv-
ous system was seen prior to 110 dpi. Initial involvement
of the peripheral nervous system was detected in the mye-
nteric and submucosal plexi of the gastro-intestinal tract.
At 110 dpi this was present in distal ileum in all cases, and
in the jejunum, colon and caecum of some cases. At 147
days the pattern was similar, but one animal did not show
PrPd in the distal ileum. At end stage disease the extent of
involvement had spread to include plexi in the jejunum
and colon of all cases, and of the caecum and duodenum
of most cases, as well as the abomasum of five and the
rumen of one case.
The only peripheral ganglion in which PrPd was detected
at 110 or 147 days was the nodose ganglion, a sensory
ganglion embedded within the vagus nerve that contains
cell bodies of sensory neurons passing from the gut to the
nucleus of the solitary tract in the brain stem. At end stage
disease there was more extensive involvement of periph-
eral ganglia, including sympathetic ganglia in some but
not all animals, but in no cases were ganglia of the sympa-
thetic chain involved.
Unchallenged in-contact lambs
Four unchallenged lambs were mixed in the same pens as
dosed animals from 28 days following challenge. The reg-
ular cleaning of pens will have avoided any gross contam-
ination of the environment, however in one pen a single
lamb was orally dosed after addition of the in-contact
lambs. All four succumbed to scrapie at an average of 666
days (638 days post initial exposure), similar to the incu-
bation period in naturally infected sheep of this genotype
kept in the flock from which inoculum RBP1 was made.
Whether this infection resulted from ingestion of remain-
ing passively excreted inoculum or infection actively shed
into the environment, i.e. natural lateral transmission,
cannot be determined with certainty.
Control sheep
Control sheep challenged with 3 g of normal brain
homogenate were killed at 13 days (n = 2), 27 days (n =
3), 95 days (n = 5) and 198 days (n = 3) after challenge.
The same tissues were examined from control as from
challenged sheep. In a single control sheep killed 198 days
after challenge a small amount of PrPd accumulation in
the mesenteric lymph nodes was detected. No PrPd was
detected elsewhere in this animal. This minimal accumu-
lation was consistent with the very early stage disease. All
other control sheep were negative on immunohistopa-
thology.
Following the surprisingly short incubation period (4
months) found in lambs challenged at 14 days of age,
eight control sheep, which had been previously orally
dosed with normal brain, were redosed at approximately
6 months of age with 1 g of RBP1 to investigate whether
the short incubation period was related to young age at
dosing. All eight sheep eventually developed clinical dis-
ease, which was confirmed by the presence of both PrPd
and vacuolar pathology in the medulla oblongata. Incu-
bation periods ranged from 198 to 639 days, average 345
days, significantly longer than for challenge at 14 days of
age, with a much greater range (Table 1).
The remaining eight control sheep were retained after all
challenged sheep had succumbed. All of these sheep
developed scrapie and were euthanased at between 880
and 1231 days of age, despite having been challenged
Table 4: Detection of PrPd in peripheral tissues from 110 days 
post-inoculation
Enteric nervous system of: Time post infection (days)
Number positive/number examined
(110) (147) (Clinical stage)
Distal ileum 10/10 2/3 10/10
Jejunum 3/10 1/3 10/10
Colon 7/10 2/3 9/9
Caecum 1/10 1/3 9/10
Duodenum 0/10 0/3 9/10
Oesophagus 0/10 0/3 0/10
Rumen 0/10 0/3 1/10
Abomasum 0/10 0/3 5/10
Celiaco-mesenteric ganglion 0/3 0/3 3/4
Stellate ganglion 0/7 0/3 2/8
Cranial Cervical ganglion 0/10 0/2 1/7
Sympathetic chain 0/4 0/3 0/7
Nodose ganglion 5/9 1/2 6/6BMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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with uninfected brain homogenate only and having been
kept isolated from challenged sheep as described.
Discussion and conclusion
The experimental disease produced in this study in VRQ
homozygous sheep challenged orally at 14 days of age
provided a highly consistent and relatively short incuba-
tion period model for the study of scrapie in the natural
host. The features of the disease resembled natural scrapie,
including spread of infection throughout the lymphoid
tissues in the pre-clinical stages of disease, clinical signs
and possibly natural transmission.
All of the challenged sheep allowed to survive beyond 16
weeks developed clinical signs at approximately 4 mpi. All
progressed to definite clinical signs necessitating euthana-
sia, with incubation periods between 6 and 7 months after
challenge. This is a remarkably short incubation period
for scrapie. Even in high incidence flocks age at death is
commonly 20–24 months [7,19], and in the flock of
sheep from which inoculum RBP1 was made all VRQ
homozygous sheep succumb to scrapie at 19–21 months
of age [8]. There have been occasional reports of natural
cases of scrapie in very young sheep but these are excep-
tional [20]. The consistently short incubation period in all
challenged sheep, whether given 1 g or 5 g of inoculum is
similar to the incubation period in subcutaneously chal-
lenged sheep [21]. It is suggested that 6–7 months is there-
fore close to the minimum incubation period for scrapie
in sheep. The consistency seen in this study is comparable
to that seen in mice challenged with mouse adapted
scrapie using overwhelming doses by the intra-cranial
route.
Challenge of sheep at 6 months of age resulted in high risk
of infection; all sheep developed disease, but with a wide
range of incubation periods from 6.5 to 21 months, on
average less than that encountered in naturally infected
flocks. Therefore it is clear that oral challenge of sheep,
regardless of age between 14 days and 6 months, results in
a shorter incubation period than natural disease, but chal-
lenge earlier leads to greater consistency in the effect of
challenge and a shorter average incubation period. This
probably reflects higher susceptibility in very young
lambs, due to a combination of several factors, including
small size giving a high ratio of dose to body weight, a
well developed and highly active gut associated lym-
phoreticular system, and possibly greater patency of the
gut to uptake of intact proteins.
Clinically affected sheep all showed typical clinical signs
associated with scrapie but those which developed disease
at 7 months of age did not have vacuolar pathology in the
brain, while those which developed disease at greater ages
did. This demonstrates that although vacuolation of the
grey matter of the brain and spinal cord is a pathological
hallmark of classical scrapie, it is not responsible for clin-
ical signs and does not develop in young animals. This
could be due to age related factors which prevent very
young animals from developing vacuolar changes, or due
to the extremely short incubation period and clinical
course in this study. An important implication of this
finding is that scrapie should be considered as a differen-
tial diagnosis for neurological disease in young animals,
and, if typical histological lesions are not present, PrPd
detection methods (immunohistochemistry, Western blot
etc.) should be applied before ruling out a diagnosis of
scrapie.
The distribution of PrPd in the sheep described here is sim-
ilar to that previously described in natural disease
[6,7,22]. Prior to detectable PrPd accumulation in any tis-
sues there was a latent period of between 3 and 4 weeks
following challenge, during which no detectable infec-
tion, or indeed residual inoculum, was present. In natural
disease it is unclear whether this latent period represents
the time taken to become infected or a period where infec-
tion is present but undetectable. In this model it is clear
that animals are infected for 3–4 weeks in the absence of
detectable PrPd even using the highly sensitive immuno-
histochemistry method used here. During this period it is
likely that replication takes place but without accumula-
tion of PrPd to levels detectable by current methods. In
other genotypes of sheep this latent period would be
expected to be longer, perhaps lasting years after natural
infection and represents a considerable challenge for the
detection of pre-clinically infected sheep in the general or
slaughter population.
Following this latent period PrPd was detected in tissues
that take up antigen directly from the gastro-intestinal
tract; the Peyer's patches and tonsils. The continuous accu-
mulation of PrPd in these tissues, and the clustering of
positive follicles demonstrated in particular in the tonsil,
indicate local replication and spread between adjacent fol-
licles. Although it is evident that infection occurred at
multiple sites, including the palatine tonsil and PP, the PP
of the distal ileum were the most frequent tissue to
become infected initially. The size of the distal ileal PP in
young ruminants is such that it probably represents quan-
titatively the most important site of uptake.
Initial spread from sites of uptake was to the draining
lymph node. The PP drain to the mesenteric lymph nodes
and the tonsils to the medial retropharyngeal nodes
(MRLN), which in turn drain to the lateral retropharyn-
geal nodes (LRLN). Labeling in the MRLN was much more
intense than in the LRLN, suggesting import of prions in
afferent lymph but minimal export of prions from the
MRLN in efferent lymph. Cell types labelled in all of theseBMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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tissues were macrophages and FDCs, as has been reported
previously [6]. We postulated that some of the immunola-
beled cells in the subcapsular sinuses may have been
veiled or afferent lymph dendritic cells (VDC), which are
carried in afferent lymph from many tissues to draining
lymph nodes and have been shown to carry prions from
the gut to draining lymph nodes in an experimental
rodent model [23]. However, for technical reasons we
have not yet been able to confirm the identity of these
cells in the formalin fixed tissues.
PrPd was not observed in any leukocytes in non-lymphoid
tissues, blood vessels or lymphatics, but macrophages and
putative VDC in secondary lymphoid organs were seen to
be infected. As monocytes and macrophages are present in
blood and acute inflammation, it would be anticipated
that occasional infected cells would be encountered if
present, but they were not. Macrophages are clearly
involved in local accumulation and transport, and possi-
bly degradation, of prions, but we found no evidence for
macrophages acting as vehicles for systemic spread.
Haematogenous spread of the infectious agent is essential
to account for the widespread dispersal of the agent to
lymphoid tissues that do not drain the gastro-intestinal
tract and to the spleen which does not receive afferent
lymph. Attempts to detect prions in blood have had vari-
able success [24,25], consistent with infection being
present but at low, and possibly varying, levels during the
incubation period.
The total quantity of PrPd detected in lymphoid tissue
increased as the incubation period progressed. Replica-
tion and accumulation can be viewed as occurring in a
series of cycles operating in parallel; initially local uptake,
replication and accumulation in individual follicles of
lymphoid tissue lining the gastrointestinal tract. Subse-
quently local infection of adjacent lymphoid follicles and
spread via lymphatic drainage to dependent lymph nodes
occurs; later there is a low level of "leakage" of prion-
infected cells from lymph nodes to the circulation, possi-
bly in efferent lymph, leading to haematogenous spread
of infection to any secondary lymphoid tissue. Infection
of lymph nodes not draining the gut could occur directly
from blood and possibly also via extravasation and return
to lymphoid tissue in afferent lymph. These cycles con-
tinue throughout the incubation period, progressively
increasing the amount of prion protein present in all lym-
phoid tissues, even after neuroinvasion has occurred.
Initial evidence of infection of the nervous system was
detection of PrPd in the enteric nervous system of the
small intestine, closest to the initial site of infection. As
disease progressed, PrPd was found in enteric nervous sys-
tem distal and proximal to this, suggesting a progressive
spread throughout the peripheral nervous system. Trans-
fer of prions to the central nervous system, the crucial pre-
cursor to clinical disease, was initially to the brain stem,
and specifically to parasympathetic neurons. No direct
evidence of transport in peripheral nerves has been found,
i.e. PrPd was never detected in nerve fibres, only in cell
bodies.
Appearance at specific sites in the CNS implicates para-
sympathetic fibres in the vagus nerve as transporters, and
appearance of PrPd in neurons of the nodose ganglion
additionally implicates sensory fibres within the vagus
nerve. There was minimal involvement of sympathetic
nervous system neurons however until late stage disease,
suggesting that central-to-peripheral spread accounts for
most infection of sympathetic ganglia. Spread via splanch-
nic nerves from the gut to the intermediolateral grey col-
umns of the thoracic spinal cord is possible, but due to the
late stage at which this occurred, central-to-peripheral
spread is difficult to exclude. Therefore the parasympa-
thetic nervous system appears to be the principal route for
prions entering the CNS.
The increased amounts of PrPd demonstrated in a reactive
compared to non-reactive lymph node, and in chronic
inflammatory tissue in the lung, show that the state of
activity of the lymphoreticular system has an influence on
the pattern of distribution of prion replication/accumula-
tion in lymphoid tissue. Thus any tissue in which chronic
inflammation occurs leading to organised lymphoid tis-
sue and germinal centre formation may contain the agent.
This observation raises the possibility that intercurrent
disease, or even vaccination, which will affect the state of
activation of the lymphoid system, might influence the
dynamics of prion accumulation; it remains to be deter-
mined whether this may lead to any effect on susceptibil-
ity to infection or progression of the disease.
The mechanism of natural spread of scrapie is unclear.
The only known source of natural shedding of the agent
into the environment is the placenta and foetal fluids, in
which PrPSc has been detected on numerous occasions
[13,26]. Attempts to identify infectivity in various excre-
tions and secretions have been unsuccessful, as reviewed
by [20]. In this study all four unchallenged but in-contact
lambs developed scrapie with an incubation period of just
under 2 years, very similar to natural disease in the heavily
infected flock from which inoculum RBP1 was made. Pre-
cautions were taken to remove passively excreted inocu-
lum from the pens before unchallenged lambs were mixed
with dosed lambs, but a single last lamb was dosed and
added to the 5 g dose group to make up numbers, and the
dosing of this lamb overlapped with contact of the 4
unchallenged lambs placed in this pen. Therefore lateral
transmission may have occurred via a small amount ofBMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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passively shed inoculum remaining in the environment,
shedding of the agent by the single last lamb, or another
as yet unidentified route. It has recently been shown that
Chronic Wasting Disease in mule deer in the USA is trans-
mitted laterally not maternally, but in that study the
source of contamination leading to lateral transmission
was not identified and could have been placenta [27]. A
similar observation has been made in natural scrapie, in
which the incubation period of scrapie in sheep was sim-
ilar whether born to likely infected or probably uninfected
ewes, again in this case transmission via the environment
contaminated at lambing time is feasible [8].
All of the control animals given brain material from a UK
scrapie free flock (not the same flock as the source of the
recipient lambs, but a native UK flock in which scrapie has
never been reported) developed disease with a mean age
at death of 1085 days. This is considerably longer than the
challenged animals, and longer than for unchallenged
lambs in direct contact with the challenged lambs, and
indeed longer than naturally occurring scrapie in this gen-
otype in a naturally high scrapie-incidence sheep flock [8].
The source of infection in these sheep is obscure, given the
precautions taken to prevent cross-contamination
between groups. It is possibly due either to undetected
levels of infection in the control inoculum or spread from
challenged sheep. The control inoculum was derived from
two sheep, negative by immunohistochemistry on the
medulla oblongata at the level of the obex. Western blot-
ting of this inoculum has given negative results. The sec-
ond possibility is that spread has occurred via trace
amounts of contaminated bedding etc., despite careful
precautions to avoid any contact between control and
infected sheep. The source of this spread could be either
residual inoculum or infection shed by the infected sheep
into the environment. Whichever is the case the amount
of infection transferred was extremely small, indicating
that the efficiency of transmission of scrapie was far higher
than previously thought. This suggests that short periods
of contact between sheep, such as during transport and at
markets, must be considered possible opportunities for
transmission under natural conditions.
The results of this study show that experimentally induced
scrapie, using a natural route of challenge in young lambs,
provides a reliable and convenient model in which to
study the dynamics of uptake and dissemination of prions
in the natural host. Using this model we have demon-
strated the existence of a latent period during which unde-
tectable replication of the agent must be occurring,
followed by local accumulation and replication that con-
tinues throughout the incubation period. Spread is
sequentially as a result of drainage in efferent lymph, hae-
matogenous spread and spread via parasympathetic and
possibly sensory nerve fibres. It is suggested that afferent
lymph dendritic cells provide a potential vehicle for the
spread of the scrapie agent within a host. Clinical disease
was associated with accumulation of disease specific prion
protein in the CNS, but not vacuolar pathology.
Methods
Sheep
Sheep used in this study were TSE free, derived originally
from New Zealand and bred in a dedicated isolation facil-
ity in the UK to ensure no contact with TSE infection. Sus-
ceptible genotypes of sheep maintained in this facility for
over six years (up to the end of the current studies) have
shown neither clinical signs of scrapie nor evidence of
infection in routine screening of the brains of sheep culled
from the flock. Lambs were produced by embryo transfer
from super-ovulated susceptible genotype ewes and car-
ried in recipient ewes of the same scrapie-free status. All
lambs were of the Cheviot breed and homozygous for the
VRQ allele of the sheep PrP gene (valine at codon 136,
arginine at codon 154 and glutamine at codon 171).
Lambs aged approximately 14 days were randomly allo-
cated to three treatment groups; two groups were chal-
lenged orally with classical scrapie brain homogenate and
one group with negative control brain homogenate. As
the optimal dose was unknown two different doses, either
1 g or 5 g, of inoculum RBP1 (see below) were given undi-
luted to 25 and 28 lambs respectively (Table 1) by placing
inoculum into the mouth directly from a syringe barrel,
enabling it to be swallowed naturally. Control sheep (n =
29) were challenged in the same way using 3 g of a
homogenate made from the brains of 2 clinically and his-
topathologically normal sheep derived from a scrapie
unaffected flock in the UK.
All lambs were maintained indoors in a dedicated facility
under normal sheep husbandry conditions and were
weaned at 6 weeks of age. Sheep were bedded on wood
shavings and pens cleaned out every other day for 28 days
post challenge to reduce the possibility of passively
excreted inoculum causing repeated infection. After this
period sheep were bedded on straw, and their diet supple-
mented with cereal based concentrate prepared on-site
using meat and bone meal free constituents derived from
TSE-free sources. Twenty-eight days after the 14 day old
lambs were dosed with positive brain homogenate, four
unchallenged lambs were mixed in the pens with the
lambs to test for lateral transmission. They remained with
the dosed sheep until clinical end-point. Control sheep
were housed in the same building as challenged sheep,
but in pens separated by a 2 m gap ensuring no physical
contact with challenged sheep. Care was taken to avoid
cross contamination between challenged and control
sheep by changing of outer clothing before entering any
pens and use of dedicated feeding, cleaning and hus-
bandry equipment for each group.BMC Veterinary Research 2009, 5:9 http://www.biomedcentral.com/1746-6148/5/9
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All inoculations were carried out in accordance with the
UK Animal (Scientific Procedures) Act 1986, under
Licence from the UK Government Home Office (Project
licence no: 70/5155). Such licence is only granted follow-
ing approval by the internal VLA ethical review process as
mandated by the Home Office.
Inoculum
Sheep scrapie brain pool RBP1 consists of a homogenate
of the whole brains of 17 sheep euthanased in the termi-
nal stages of scrapie in which disease was confirmed by
histopathological examination of the brain stem. The
sheep all originated in the institute's own flock of natu-
rally scrapie infected sheep and comprised a mixture of
VRQ and ARQ homozygotes and heterozygotes. Titration
of this inoculum in RIII mice has given a titre of 103.96
mouse i.c/i.p LD50/g.
Necropsies
Sheep were euthanased by intravenous injection of penta-
barbitone at pre-determined time points as detailed in
Table 2, or as soon as they showed definite clinical signs
of scrapie. Incubation periods given are the dates to death
at the onset of definite clinical signs (equivocal signs sug-
gestive of scrapie were noted earlier than this). Tissues
were collected into 10% neutral buffered formalin. Small
intestinal tissues were collected within 2 minutes of death
for optimal mucosal preservation. Tissues were processed
and embedded in wax using routine histological proce-
dures after 5 days fixation.
Immunohistochemistry
5 μm sections were cut and immunolabeled with rat mon-
oclonal antibody R145, kindly provided by Mr R Jackman,
VLA-Weybridge, using a DAKO Techmate automated
immunolabeller and counterstained using haematoxylin.
Using this method patterns of disease specific immunla-
beling are similar to published descriptions [6] and no
immunolabeling is detected in normal tissue, therefore
PrP detected in challenged animals is considered abnor-
mal, termed disease specific PrP.
Western blotting
using a modification of the Prionics-check test was per-
formed on fresh obex samples as previously described
[17].
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